Pharmaceutical Origin Transparency Act of 2018

Pharmaceutical Origin Transparency Act of 2018

This bill amends the Federal Food, Drug, and Cosmetic Act to require a drug manufacturer to publish information about each country in which its drugs are manufactured. (A drug is manufactured in a country if the active pharmaceutical ingredient is manufactured in such country.)

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[S. 3105 Introduced in Senate (IS)]

<DOC>






115th CONGRESS
  2d Session
                                S. 3105

To require manufacturers of drugs to post the names of the countries in 
     which their drugs are manufactured on their internet websites.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             June 21, 2018

Mrs. McCaskill introduced the following bill; which was read twice and 
  referred to the Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
To require manufacturers of drugs to post the names of the countries in 
     which their drugs are manufactured on their internet websites.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Pharmaceutical Origin Transparency 
Act of 2018''.

SEC. 2. INFORMATION ABOUT DRUG MANUFACTURING.

    Section 301 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
331) is amended by adding at the end the following:
    ``(eee)(1) The introduction or delivery for introduction into 
interstate commerce of any drug subject to section 503(b)(1), unless 
the manufacturer of such drug maintains on its internet website 
information about each country in which such drug is manufactured.
    ``(2) For purposes of this paragraph, a drug is manufactured in a 
country if the active pharmaceutical ingredient is manufactured in such 
country.''.
                                 <all>